Published in Subst Abus on January 01, 2008
Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clin Chem (2013) 1.29
Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav (2011) 1.22
Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. Drug Alcohol Depend (2010) 1.13
Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs. J Pharmacol Exp Ther (2010) 1.09
Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones. Br J Pharmacol (2010) 1.03
Effects of chronic buspirone treatment on cocaine self-administration. Neuropsychopharmacology (2012) 0.93
Building smart cannabis policy from the science up. Int J Drug Policy (2017) 0.90
Simultaneous quantification of Δ(9)-tetrahydrocannabinol, 11-nor-9-carboxy-tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography-high resolution mass spectrometry. J Chromatogr A (2013) 0.82
"Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays. Life Sci (2013) 0.82
Medical marijuana use and suicide attempt in a patient with major depressive disorder. Am J Psychiatry (2011) 0.82
Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg. Psychopharmacology (Berl) (2016) 0.78
Synaptic neurotransmission depression in ventral tegmental dopamine neurons and cannabinoid-associated addictive learning. PLoS One (2010) 0.78
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings. Drug Alcohol Depend (2016) 0.76
Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users. Psychopharmacology (Berl) (2017) 0.75
TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER. Int J Med Biol Front (2012) 0.75
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [(11)C]CURB. Biol Psychiatry (2016) 0.75
U.S. Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology (2017) 0.75
Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (1990) 13.60
The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abuse Treat (2004) 7.15
Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol (2000) 4.34
Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry (1994) 4.31
Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol (2001) 4.03
From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology (2002) 3.56
Early-onset drug use and risk of later drug problems. Drug Alcohol Depend (1995) 3.42
Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry (2001) 3.27
Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry (2001) 3.26
Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry (2004) 3.26
Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol (2004) 2.87
The time course and significance of cannabis withdrawal. J Abnorm Psychol (2003) 2.70
Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol (2000) 2.68
A cannabinoid mechanism in relapse to cocaine seeking. Nat Med (2001) 2.65
Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. Am J Drug Alcohol Abuse (2001) 2.63
Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001. Drug Alcohol Depend (2005) 2.57
Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction (1999) 2.51
Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) (1999) 2.27
Juvenile drug court: enhancing outcomes by integrating evidence-based treatments. J Consult Clin Psychol (2006) 2.23
Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A (2003) 2.21
Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. J Consult Clin Psychol (2006) 2.15
Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology (2004) 2.09
Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry (2001) 2.02
Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry (2004) 2.01
Epidemiological patterns of extra-medical drug use in the United States: evidence from the National Comorbidity Survey Replication, 2001-2003. Drug Alcohol Depend (2007) 1.94
Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc (2003) 1.91
Treating adult marijuana dependence: a test of the relapse prevention model. J Consult Clin Psychol (1994) 1.87
Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci (2000) 1.85
Abstinence rates following behavioral treatments for marijuana dependence. Addict Behav (2006) 1.83
A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abuse Treat (2001) 1.72
Adult marijuana users seeking treatment. J Consult Clin Psychol (1993) 1.57
Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans. Psychopharmacology (Berl) (2002) 1.47
National Highway Traffic Safety Administration (NHTSA) notes. Marijuana and alcohol combined severely impede driving performance. Ann Emerg Med (2000) 1.46
Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. Am J Addict (2004) 1.46
The marijuana withdrawal syndrome: diagnosis and treatment. Curr Psychiatry Rep (2005) 1.43
Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers. Neuropsychopharmacology (2006) 1.37
Bupropion SR worsens mood during marijuana withdrawal in humans. Psychopharmacology (Berl) (2001) 1.36
A contingency management intervention for adolescent marijuana abuse and conduct problems. J Am Acad Child Adolesc Psychiatry (2005) 1.33
Treatment of marijuana dependence: a review of the literature. J Subst Abuse Treat (2003) 1.28
Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend (2002) 1.24
Nefazodone decreases anxiety during marijuana withdrawal in humans. Psychopharmacology (Berl) (2002) 1.22
Relapse in outpatient treatment for marijuana dependence. J Subst Abuse Treat (2003) 1.20
Attributes of long-term heavy cannabis users: a case-control study. Psychol Med (2003) 1.11
Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology (Berl) (1999) 1.05
Services research on adolescent drug treatment. Commentary on "The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials". J Subst Abuse Treat (2004) 1.05
Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addict Behav (1999) 1.03
Dependence on tetrahydrocannabinol in rhesus monkeys. J Pharmacol Exp Ther (1986) 1.02
The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. Am Heart J (2006) 1.01
Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation. J Neurosci (2001) 1.00
Buspirone for treatment of marijuana dependence: a pilot study. Am J Addict (2006) 0.99
Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. Psychopharmacology (Berl) (1981) 0.93
Assessing need for marijuana dependence treatment through an anonymous telephone interview. Int J Addict (1987) 0.84
Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations. J Anal Toxicol (1993) 0.76
Establishing the computer-patient working alliance in automated health behavior change interventions. Patient Educ Couns (2005) 2.93
DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry (2013) 2.89
Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology (2007) 2.42
The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) (2001) 2.02
The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics (2006) 1.98
Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology (2007) 1.97
Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol (2007) 1.90
Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J (2006) 1.81
Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend (2009) 1.77
Risk of harm among gamblers in the general population as a function of level of participation in gambling activities. Addiction (2006) 1.75
Substance use disorders: sex differences and psychiatric comorbidities. Can J Psychiatry (2003) 1.53
Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug Alcohol Depend (2009) 1.53
Cue-induced brain activity in pathological gamblers. Biol Psychiatry (2005) 1.51
The DSM-5 field trials and reliability of alcohol use disorder. Am J Psychiatry (2013) 1.48
Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans. Psychopharmacology (Berl) (2002) 1.47
Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ (2004) 1.44
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol (2008) 1.41
Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone. Addiction (2013) 1.39
Pharmacotherapy of methamphetamine addiction: an update. Subst Abus (2008) 1.36
A contingency management intervention for adolescent marijuana abuse and conduct problems. J Am Acad Child Adolesc Psychiatry (2005) 1.33
Gender similarities and differences: the prevalence and course of alcohol- and other substance-related disorders. J Addict Dis (2003) 1.33
Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem (2007) 1.32
Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend (2002) 1.24
Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) (2012) 1.21
Pharmacotherapy for cannabis dependence: how close are we? CNS Drugs (2009) 1.19
Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure. Psychopharmacology (Berl) (2005) 1.18
Relationship between craving and personality in treatment-seeking women with substance-related disorders. BMC Psychiatry (2003) 1.16
Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J (2009) 1.16
The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend (2003) 1.16
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend (2010) 1.15
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology (2013) 1.13
6-[18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matter. Synapse (2004) 1.11
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers. Psychopharmacology (Berl) (2010) 1.11
Intranasal cocaine in humans: effects of sex and menstrual cycle. Pharmacol Biochem Behav (2006) 1.09
Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine. Neurotoxicol Teratol (2008) 1.07
A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) (2011) 1.06
Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). Am J Drug Alcohol Abuse (2007) 1.05
Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol (2009) 1.05
The impact of gender, depression, and personality on craving. J Addict Dis (2007) 1.04
The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day. Drug Alcohol Depend (2007) 1.03
Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biol Psychiatry (2012) 1.03
Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. J Clin Exp Neuropsychol (2007) 1.03
Modafinil does not serve as a reinforcer in cocaine abusers. Drug Alcohol Depend (2009) 1.02
Brief motivational treatment for problem gambling: a 24-month follow-up. Psychol Addict Behav (2004) 1.02
Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol (2011) 1.00
Chronic exposure to nicotine is associated with reduced reward-related activity in the striatum but not the midbrain. Biol Psychiatry (2011) 0.99
Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers. Addict Biol (2012) 0.99
Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. Int Rev Psychiatry (2009) 0.98
Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology (Berl) (2002) 0.98
The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age. Am J Perinatol (2011) 0.98
Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend (2004) 0.98
Cardiovascular and subjective effects of repeated smoked cocaine administration in experienced cocaine users. Drug Alcohol Depend (2009) 0.98
Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance. Drug Alcohol Depend (2010) 0.97
Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology (2013) 0.97
The influence of substance dependence and mood disorders on outcome from pathological gambling: five-year follow-up. J Gambl Stud (2009) 0.96
Retrospective and prospective reports of precipitants to relapse in pathological gambling. J Consult Clin Psychol (2004) 0.96
Decision-making in long-term cocaine users: Effects of a cash monetary contingency on Gambling task performance. Drug Alcohol Depend (2009) 0.96
A framework for reporting outcomes in problem gambling treatment research: the Banff, Alberta Consensus. Addiction (2006) 0.96
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study. Psychopharmacology (Berl) (2010) 0.96
Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence. Addiction (2005) 0.95
A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers. Addict Biol (2012) 0.94
Modafinil attenuates disruptions in cognitive performance during simulated night-shift work. Neuropsychopharmacology (2005) 0.93
Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects. Pharmacol Biochem Behav (2004) 0.93
Comparison of craving between pathological gamblers and alcoholics. Alcohol Clin Exp Res (2005) 0.93
Biotechnology and the treatment of addictive disorders: new opportunities. BioDrugs (2007) 0.92
Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel report. Drug Alcohol Depend (2009) 0.92
Intravenous cocaine and QT variability. J Cardiovasc Electrophysiol (2006) 0.91
Infant temperament and high-risk environment relate to behavior problems and language in toddlers. J Dev Behav Pediatr (2011) 0.91
Combined effects of methamphetamine and zolpidem on performance and mood during simulated night shift work. Pharmacol Biochem Behav (2005) 0.91
Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence. Drug Alcohol Depend (2006) 0.90
Comorbid depression among untreated illicit opiate users: results from a multisite Canadian study. Can J Psychiatry (2005) 0.89
Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory. Hum Psychopharmacol (2007) 0.89
Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. Biol Psychol (2010) 0.89
Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence. Addiction (2005) 0.88
The effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humans. Exp Clin Psychopharmacol (2007) 0.88
Biological markers of cocaine addiction: implications for medications development. Addict Biol (2003) 0.88
Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure. Behav Pharmacol (2007) 0.88
Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work. Psychopharmacology (Berl) (2003) 0.87
Relational agents in clinical psychiatry. Harv Rev Psychiatry (2010) 0.87
Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned. Addiction (2005) 0.87
The association between childhood maltreatment and gambling problems in a community sample of adult men and women. Psychol Addict Behav (2010) 0.87
Comorbid psychiatric and substance abuse disorders: recent treatment research. Subst Abus (2008) 0.87
Lorcaserin suppresses oxycodone self-administration and relapse vulnerability in rats. ACS Chem Neurosci (2017) 0.87
Modafinil decreases food intake in humans subjected to simulated shift work. Pharmacol Biochem Behav (2008) 0.86
The effect of prenatal methamphetamine exposure on attention as assessed by continuous performance tests: results from the Infant Development, Environment, and Lifestyle study. J Dev Behav Pediatr (2013) 0.86
Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates. Pharmacol Biochem Behav (2007) 0.86
Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition. Psychol Addict Behav (2012) 0.86
Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug Alcohol Depend (2006) 0.86
The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity. Addiction (2007) 0.86
Does providing extended relapse prevention bibliotherapy to problem gamblers improve outcome? J Gambl Stud (2007) 0.85
Novel medications to treat addictive disorders. Curr Psychiatry Rep (2008) 0.85
Zolpidem-related effects on performance and mood during simulated night-shift work. Exp Clin Psychopharmacol (2003) 0.84
Genetics and alcoholism: how close are we to potential clinical applications? Can J Psychiatry (2006) 0.84
Marijuana's dose-dependent effects in daily marijuana smokers. Exp Clin Psychopharmacol (2013) 0.84
The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans. Exp Clin Psychopharmacol (2003) 0.83
Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers. Behav Pharmacol (2012) 0.83
Examining the predictive validity of low-risk gambling limits with longitudinal data. Addiction (2011) 0.83
Memantine increases cardiovascular but not behavioral effects of cocaine in methadone-maintained humans. Pharmacol Biochem Behav (2006) 0.83
Personality changes in women recovering from substance-related dependence. J Addict Dis (2006) 0.81